Howard Hughes Medical Institute’s Sempra SRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SRE
VCM
VPM
Howard Hughes Medical Institute's SRE Position: Q1 2026 in Review
Howard Hughes Medical Institute sold out of Sempra (SRE) in Q1 2026, closing a stake of 140 shares — an estimated $12.4K sold.
Howard Hughes Medical Institute first reported a position in SRE in Q2 2025 and held it in 3 quarters. The position peaked at $12.6K in Q3 2025. 1,266 funds tracked by Wall St. Rank hold SRE as of Q1 2026.
- Howard Hughes Medical Institute reported no remaining Sempra position as of Q1 2026 after selling out during the quarter.
- Howard Hughes Medical Institute sold 140 Sempra shares in Q1 2026, an estimated $12.4K.
- Howard Hughes Medical Institute first reported a position in Sempra in Q2 2025 and held it in 3 quarters.
- Howard Hughes Medical Institute's Sempra position peaked at $12.6K in Q3 2025.
- 1,266 funds tracked by Wall St. Rank held Sempra as of Q1 2026.
Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.